Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients.
暂无分享,去创建一个
R. Price | D. Kyle | N. White | F O ter Kuile | F Nosten | C Luxemburger | D Kyle | P Teja-Isavatharm | L Phaipun | R Price | T Chongsuphajaisiddhi | N J White | F. Nosten | C. Luxemburger | L. Phaipun | T. Chongsuphajaisiddhi | F. Kuile | R. Price | F. T. ter Kuile | P. Teja-Isavatharm | N. White
[1] N. White,et al. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[2] A. Hall,et al. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria. , 1977, British medical journal.
[3] N. White,et al. Clinical Pharmacokinetics of Mefloquine , 1990, Clinical pharmacokinetics.
[4] R. N. Brogden,et al. Mefloquine , 1993, Drugs.
[5] M. Molyneux,et al. Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine. , 1987, British journal of clinical pharmacology.
[6] D. Kyle,et al. Cardiac effects of antimalarial treatment with halofantrine , 1993, The Lancet.
[7] H. Webster,et al. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria , 1993, The Lancet.
[8] J. Karbwang,et al. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria. , 1994, Bulletin of the World Health Organization.
[9] S. Looareesuwan,et al. Drug resistant malaria, with special reference to Thailand. , 1992, The Southeast Asian journal of tropical medicine and public health.
[10] W. Wernsdorfer,et al. A phase II clinical trial of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. , 1983, Bulletin of the World Health Organization.
[11] L. Pang,et al. Mefloquine kinetics in cured and recrudescent patients with acute falciparum malaria and in healthy volunteers , 1990, Clinical pharmacology and therapeutics.
[12] R. Steketee,et al. Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. , 1990, Bulletin of the World Health Organization.
[13] J. Karbwang,et al. Pharmacokinetics and pharmacodynamics of mefloquine in Thai patients with acute falciparum malaria. , 1991, Bulletin of the World Health Organization.
[14] H. Webster,et al. Mefloquine-resistant falciparum malaria on the Thai-Burmese border , 1991, The Lancet.
[15] P. Phintuyothin,et al. Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine. , 1979, Bulletin of the World Health Organization.
[16] G. Cook. Practical chemotherapy of malaria. Report of a WHO Scientific Group. , 1990, World Health Organization technical report series.
[17] A. Walker,et al. Predictors of treatment failure in multiple drug-resistant falciparum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand. , 1993, The American journal of tropical medicine and hygiene.
[18] P. Phillips-Howard,et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa , 1993, The Lancet.
[19] T. Harinasuta,et al. TRIALS OF MEFLOQUINE IN VIVAX AND OF MEFLOQUINE PLUS 'FANSIDAR' IN FALCIPARUM MALARIA , 1985, The Lancet.
[20] J. Karbwang,et al. Effect of mefloquine on electrocardiographic changes in uncomplicated falciparum malaria patients. , 1992, The Southeast Asian journal of tropical medicine and public health.
[21] H. Webster,et al. High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. , 1992, The Journal of infectious diseases.
[22] E L Kaplan. NON-PARAMETRIC ESTIMATION FROM INCOMPLETE OBSERVATION , 1958 .
[23] N. White,et al. Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[24] J. M. Kofi Ekue,et al. A double-blind comparative clinical trial of mefloquine and chloroquine in symptomatic falciparum malaria. , 1983, Bulletin of the World Health Organization.
[25] W. Wernsdorfer,et al. A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand. , 1987, Bulletin of the World Health Organization.